Pathophysiology of the plasminogen/plasmin systemLIJNEN, H. R.International journal of clinical & laboratory research. 1996, Vol 26, Num 1, pp 1-6, issn 0940-5437Article

The Tissue-Type Plasminogen Activator StoryCOLLEN, D; LIJNEN, H. R.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 8, pp 1151-1155, issn 1079-5642, 5 p.Article

Strategies for the improvement of thrombolytic agentsLIJNEN, H. R; COLLEN, D.Thrombosis and haemostasis. 1991, Vol 66, Num 1, pp 88-110, issn 0340-6245Article

New strategies in the development of thrombolytic agentsLIJNEN, H. R; COLLEN, D.Blut. 1988, Vol 57, Num 4, pp 147-162, issn 0006-5242Article

Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activatorLIJNEN, H. R; COLLEN, D.Thrombosis research. 1986, Vol 43, Num 6, pp 687-690, issn 0049-3848Article

Development of thrombolytic agentsLIJNEN, H. R; COLLEN, D.Biotechnology advances. 1993, Vol 11, Num 1, pp 115-130, issn 0734-9750Article

Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential ?COLLEN, D; LIJNEN, H. R.Blood. 1994, Vol 84, Num 3, pp 680-686, issn 0006-4971Article

Basal and clinical aspects of fibrinolysis and thrombolysisCOLLEN, D; LIJNEN, H. R.Blood. 1991, Vol 78, Num 12, pp 3114-3124, issn 0006-4971Article

Towards the development of improved thrombolytic agentsLIJNEN, H. R; COLLEN, D.British journal of haematology. 1991, Vol 77, Num 3, pp 261-266, issn 0007-1048Article

Molecular mechanisms of thrombolysis : implications for therapyCOLLEN, D; LIJNEN, H. R.Biochemical pharmacology. 1990, Vol 40, Num 2, pp 177-186, issn 0006-2952, 10 p.Article

Matrix metalloproteinase system deficiencies and matrix degradationLIJNEN, H. R; COLLEN, D.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 837-845, issn 0340-6245Article

Thrombolytic agents in developmentVERSTRAETE, M; LIJNEN, H. R; COLLEN, D et al.Drugs (Basel). 1995, Vol 50, Num 1, pp 29-42, issn 0012-6667Article

Regulation by α₂-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasmaSILENCE, K; COLLEN, D; LIJNEN, H. R et al.Blood. 1993, Vol 82, Num 4, pp 1175-1183, issn 0006-4971Article

A monoclonal antibody specific for Lys-plasminogen: application to the study of the activation pathways of plasminogen in vivoHOLVOET, P; LIJNEN, H. R; COLLEN, D et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 22, pp 12106-12111, issn 0021-9258Article

Multiple forms of plasminogen activator in human breast tumorsÓGRADY, P; LIJNEN, H. R; DUFFY, M. J et al.Cancer research (Baltimore). 1985, Vol 45, Num 12, pp 6216-6218, issn 0008-5472Article

Biological and thrombolytic properties of proenzyme and active forms of human urokinase. II: Turnover of natural and recombinant urokinase in rabbits and squirrel monkeysCOLLEN, D; DE COCK, F; LIJNEN, H. R et al.Thrombosis and haemostasis. 1984, Vol 52, Num 1, pp 24-26, issn 0340-6245Article

Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitroZAMARRON, C; LIJNEN, H. R; COLLEN, D et al.Thrombosis research. 1984, Vol 35, Num 3, pp 335-345, issn 0049-3848Article

StaphylokinaseLIJNEN, H. R; COLLEN, D.Handbook of experimental pharmacology. 2001, Vol 146, pp 425-449, issn 0171-2004Article

Interaction between staphylokinase, plasmin(ogen), and α₂-antiplasmin : recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by α₂-antiplasminSILENCE, K; COLLEN, D; LIJNEN, H. R et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 13, pp 9811-9816, issn 0021-9258Article

Interaction of staphylokinase with different molecular forms of plasminogenLIJNEN, H. R; VAN HOEF, B; COLLEN, D et al.European journal of biochemistry (Print). 1993, Vol 211, Num 1-2, pp 91-97, issn 0014-2956Article

Towards better thrombotytic therapyCOLLEN, D; LIJNEN, H. R; GOLD, H. K et al.Progress in cardiovascular diseases. 1991, Vol 34, Num 2, pp 101-112, issn 0033-0620Article

Activation with plasmin of two-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombinLIJNEN, H. R; VAN HOEF, B; COLLEN, D et al.European journal of biochemistry (Print). 1987, Vol 169, Num 2, pp 359-364, issn 0014-2956Article

A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen: role of LBS in the regulation of fibrinolysisHOLVOET, P; LIJNEN, H. R; COLLEN, D et al.European journal of biochemistry (Print). 1986, Vol 157, Num 1, pp 65-69, issn 0014-2956Article

Comparative kinetic analysis of the activation of human plasminogen by natural adn recombinant single-chain urokinase-type plasminogen activatorLIJNEN, H. R; VAN HOEF, B; COLLEN, D et al.Biochimica et biophysica acta. 1986, Vol 884, Num 3, pp 402-408, issn 0006-3002Article

Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinaseLIJNEN, H. R; VAN HOEF, B; COLLEN, D et al.European journal of biochemistry (Print). 1984, Vol 144, Num 3, pp 541-544, issn 0014-2956Article